Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 A Multidisciplinary Perspective /
This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first books to give a comprehensive overview of mRNA vaccines against COVID-19 and the only one that addresses this topic from a broad multidisciplinary...
Na minha lista:
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Recurso Electrónico livro electrónico |
| Idioma: | inglês |
| Publicado em: |
Cham :
Springer International Publishing : Imprint: Springer,
2023.
|
| Edição: | 1st ed. 2023. |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/978-3-031-18903-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Sumário:
- Chapter 1: Introduction
- Part I: Scientifi Underpinnings, early expectations, and emerging challenges from the global inoculation experience
- Chapter 2: Appraisal of Some of the Key Postulates Underlying mRNA Vaccines
- Chapter 3: Relevance for mRNA vaccine safety
- Chapter 4: From Challenges to Opportunities and Open Questions
- Chapter 5: The challenge of evaluating vaccine safety and effectiveness
- Chapter 6: Safeguarding against the analog of antimicrobial-resistance development
- Chapter 7: Scales, pseudoscales, the human factor, and a way forward
- Part II: A deeper dive into mRNA vaccine safety and security, and developments until Delta
- Chapter 8: mRNA Vaccine safety and efficacy - official criteria when AEs are caused by the injection
- Chapter 9: mRNA Covid-19 vaccines best reflect effective pharmaceuticals - basic considerations and LNPs
- Chapter 10: mRNA Covid-19 pharmaceuticals and the spike antigen
- Chapter 11: Other facets of SARS-CoV-2 immunity, the risk of immune tolerance and T cell exhaustion
- Part III: The Omicron variants
- Chapter 12: Omicron
- Chapter 13: Conclusion.